Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
March 10, 2012
The economic value of a visceral leishmaniasis vaccine in Bihar state, India
Bruce Y Lee, Kristina M Bacon, Mirat Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2025
Reply to: Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer
Mirat Shah, Mallorie H Fiero, Joyce Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2025
Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology
Laura A Levit, Mirat Shah, Mark J Ratain, et al.
JCO Oncology Practice
|
April 28, 2020
Oncology Fellow-Led Quality Improvement Project to Improve Rates of Palliative Care Utilization in Patients With Advanced Cancer
Ramy Sedhom, Arjun Gupta, Mirat Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2025
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor-Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2-Low or Human Epidermal Growth Factor Receptor 2-Ultralow Breast Cancer
Asma Dilawari, Hui Zhang, Mirat Shah, et al.
JCO Oncology Practice
|
February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study
Mirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 5, 2011
Economic value of dengue vaccine in Thailand
Bruce Y Lee, Diana L Connor, Sarah B Kitchen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2022
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
Jeanne Fourie Zirkelbach, Mirat Shah, Jonathon Vallejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer
Mirat Shah, Christy L Osgood, Anup K Amatya, et al.
Journal of Neuro-Oncology
|
June 22, 2021
US Food and Drug Administration regulatory updates in neuro-oncology
Gautam U Mehta, Amy K Barone, Diana Bradford, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
The American Journal of Tropical Medicine and Hygiene
|
March 10, 2012
The economic value of a visceral leishmaniasis vaccine in Bihar state, India
Bruce Y Lee, Kristina M Bacon, Mirat Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2025
Reply to: Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer
Mirat Shah, Mallorie H Fiero, Joyce Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2025
Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology
Laura A Levit, Mirat Shah, Mark J Ratain, et al.
JCO Oncology Practice
|
April 28, 2020
Oncology Fellow-Led Quality Improvement Project to Improve Rates of Palliative Care Utilization in Patients With Advanced Cancer
Ramy Sedhom, Arjun Gupta, Mirat Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2025
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor-Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2-Low or Human Epidermal Growth Factor Receptor 2-Ultralow Breast Cancer
Asma Dilawari, Hui Zhang, Mirat Shah, et al.
JCO Oncology Practice
|
February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study
Mirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 5, 2011
Economic value of dengue vaccine in Thailand
Bruce Y Lee, Diana L Connor, Sarah B Kitchen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2022
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
Jeanne Fourie Zirkelbach, Mirat Shah, Jonathon Vallejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer
Mirat Shah, Christy L Osgood, Anup K Amatya, et al.
Journal of Neuro-Oncology
|
June 22, 2021
US Food and Drug Administration regulatory updates in neuro-oncology
Gautam U Mehta, Amy K Barone, Diana Bradford, et al.
Page
of 4